Duloxetin for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients with depression.
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2016
Price : $35 *
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Peripheral neuropathies
- Focus Therapeutic Use
- 13 Sep 2016 Status changed from recruiting to discontinued.
- 10 Jul 2014 New trial record